IDO1/TDO-IN-4
|
I649092-100mg
|
≥99% |
461424-21-5 |
100mg
|
¥ 9400.9
|
期货,请咨询 |
阿拉丁 |
Imatinib-d4
|
I649056-5mg
|
≥99% |
1134803-16-9 |
5mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Imatinib-d4
|
I649056-1mg
|
≥99% |
1134803-16-9 |
1mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
ILK-IN-3
|
I649033-5mg
|
≥99% |
6975-75-3 |
5mg
|
¥ 1900.9
|
期货,请咨询 |
阿拉丁 |
ILK-IN-3
|
I649033-50mg
|
≥99% |
6975-75-3 |
50mg
|
¥ 9000.9
|
期货,请咨询 |
阿拉丁 |
ILK-IN-3
|
I649033-25mg
|
≥99% |
6975-75-3 |
25mg
|
¥ 5900.9
|
期货,请咨询 |
阿拉丁 |
ILK-IN-3
|
I649033-10mg
|
≥99% |
6975-75-3 |
10mg
|
¥ 3050.9
|
期货,请咨询 |
阿拉丁 |
IDH1 Inhibitor 7-d2
|
I649015-1mg
|
≥99% |
2135309-51-0 |
1mg
|
¥ 11500.9
|
期货,请咨询 |
阿拉丁 |
IV-361
|
I649000-5mg
|
≥98% |
2055741-39-2 |
5mg
|
¥ 10500.9
|
期货,请咨询 |
阿拉丁 |
IV-361
|
I649000-10mg
|
≥98% |
2055741-39-2 |
10mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
I-BET567
|
I648937-5mg
|
≥99% |
1887237-54-8 |
5mg
|
¥ 7400.9
|
期货,请咨询 |
阿拉丁 |
I-BET567
|
I648937-10mg
|
≥99% |
1887237-54-8 |
10mg
|
¥ 11700.9
|
期货,请咨询 |
阿拉丁 |
Irdabisant
|
I648925-5mg
|
≥98% |
1005402-19-6 |
5mg
|
¥ 2800.9
|
现货 |
阿拉丁 |
Irdabisant
|
I648925-50mg
|
≥98% |
1005402-19-6 |
50mg
|
¥ 11000.9
|
现货 |
阿拉丁 |
Irdabisant
|
I648925-25mg
|
≥98% |
1005402-19-6 |
25mg
|
¥ 7500.9
|
现货 |
阿拉丁 |
Irdabisant
|
I648925-1mg
|
≥98% |
1005402-19-6 |
1mg
|
¥ 1100.9
|
现货 |
阿拉丁 |
Irdabisant
|
I648925-10mg
|
≥98% |
1005402-19-6 |
10mg
|
¥ 4200.9
|
现货 |
阿拉丁 |
Iridin
|
I648899-5mg
|
≥98% |
491-74-7 |
5mg
|
¥ 2350.9
|
期货,请咨询 |
阿拉丁 |
Iridin
|
I648899-1mg
|
≥98% |
491-74-7 |
1mg
|
¥ 895.9
|
期货,请咨询 |
阿拉丁 |
Iridin
|
I648899-10mg
|
≥98% |
491-74-7 |
10mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Ibiglustat (L-Malic acid)
|
I648887-5mg
|
≥98% |
1629063-78-0 |
5mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
Ibiglustat (L-Malic acid)
|
I648887-2mg
|
≥98% |
1629063-78-0 |
2mg
|
¥ 700.9
|
期货,请咨询 |
阿拉丁 |
Ibiglustat (L-Malic acid)
|
I648887-10mg
|
≥98% |
1629063-78-0 |
10mg
|
¥ 2300.9
|
期货,请咨询 |
阿拉丁 |
Istaroxime hydrochloride
|
I648885-5mg
|
≥98% |
374559-48-5 |
5mg
|
¥ 2158.9
|
期货,请咨询 |
阿拉丁 |